Clinical response and pathway-specific correlates following TIGIT–LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial
Shambavi Richard, Alexander M. Lesokhin, Barry Paul, Jonathan L. Kaufman, Matthew J. Pianko, Noa Biran, Ravi Vij, Deon B. Doxie, Maryam I. Azeem, Mercedes Martillo, Katie Wozniak, Hearn Jay Cho, Kavita M. Dhodapkar, Madhav V. Dhodapkar
Topics & Concepts
TIGITPomalidomideMedicineT cellDexamethasoneImmunologyCancer researchInternal medicineMultiple myelomaImmune systemBortezomibImmune Cell Function and InteractionCAR-T cell therapy researchCancer Immunotherapy and Biomarkers